mitomycin has been researched along with curcumin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mukherjee, A; Mukhopadhyay, MJ; Saha, A | 1 |
| Afzal, M; Ara, G; Beg, T; Gupta, J; Siddique, YH | 1 |
| Lu, YY; Su, SB; Wang, XF; Zhang, H; Zhou, QM | 1 |
| Hiddingh, S; Hoatlin, ME; Landais, I; McCarroll, M; Snyder, JP; Sun, A; Turker, MS; Yang, C | 1 |
| Huang, S; Liu, XJ; Lu, YY; Su, SB; Wang, XF; Zhang, H; Zhou, QM | 1 |
| Chiu, YF; Ko, JC; Kuo, YH; Lin, YW; Tsai, MS; Weng, SH | 1 |
| Chen, HJ; Chiu, YF; Kuo, YH; Lin, YW; Tsai, MS; Weng, SH | 1 |
| Liu, XJ; Lu, YY; Su, SB; Wang, XF; Zhang, H; Zhou, QM | 1 |
| Dubiel, W; Feist, M; Huang, X; Müller, JM; Rau, B | 1 |
| Chen, QL; Du, J; Lu, YY; Su, SB; Wang, XF; Zhang, H; Zhou, QM | 1 |
| Chen, Q; Huang, S; Lu, Y; Su, S; Ye, M; Zhang, H; Zhou, Q | 1 |
| Chang, C; Chen, CC; Chen, J; Huang, CP; Liu, G; Messing, E; Yeh, S; Zhang, Y | 1 |
12 other study(ies) available for mitomycin and curcumin
| Article | Year |
|---|---|
Studies on the anticlastogenic effect of turmeric and curcumin on cyclophosphamide and mitomycin C in vivo.
Topics: Animals; Antimutagenic Agents; Chromosome Aberrations; Curcumin; Cyclophosphamide; Male; Mice; Mitomycin; Mutagens | 1998 |
Assessment of cell viability, lipid peroxidation and quantification of DNA fragmentation after the treatment of anticancerous drug mitomycin C and curcumin in cultured human blood lymphocytes.
Topics: Antibiotics, Antineoplastic; Antioxidants; Cell Survival; Cells, Cultured; Curcumin; DNA Fragmentation; Humans; Lipid Peroxidation; Lymphocytes; Male; Mitomycin | 2010 |
Curcumin reduced the side effects of mitomycin C by inhibiting GRP58-mediated DNA cross-linking in MCF-7 breast cancer xenografts.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cross-Linking Reagents; Curcumin; DNA; DNA Damage; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Mammary Neoplasms, Experimental; MAP Kinase Signaling System; Mice; Mitomycin; Neoplasm Transplantation; p38 Mitogen-Activated Protein Kinases; Protein Disulfide-Isomerases; Transplantation, Heterologous | 2009 |
Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors.
Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Curcumin; DNA-Binding Proteins; Drug Synergism; Fanconi Anemia; Fanconi Anemia Complementation Group D2 Protein; HeLa Cells; Humans; Ketones; Mitomycin; Protein Serine-Threonine Kinases; Tumor Suppressor Proteins; Xenopus | 2009 |
Curcumin improves MMC-based chemotherapy by simultaneously sensitising cancer cells to MMC and reducing MMC-associated side-effects.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chemoprevention; Chemotherapy, Adjuvant; Curcumin; Drug Synergism; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mitomycin | 2011 |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Curcumin; Cytotoxins; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitomycin; Rad51 Recombinase; RNA, Small Interfering | 2011 |
Enhancement of mitomycin C-induced cytotoxicity by curcumin results from down-regulation of MKK1/2-ERK1/2-mediated thymidine phosphorylase expression.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Curcuma; Curcumin; Down-Regulation; Drug Synergism; Humans; Lung Neoplasms; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mitomycin; Phosphorylation; Thymidine Phosphorylase | 2012 |
Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Curcumin; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Mitomycin | 2011 |
Can hyperthermic intraperitoneal chemotherapy efficiency be improved by blocking the DNA repair factor COP9 signalosome?
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; COP9 Signalosome Complex; Curcumin; DNA Damage; Enzyme Activation; HT29 Cells; Humans; Hyperthermia, Induced; MicroRNAs; Mitomycin; Multiprotein Complexes; Peptide Hydrolases; Peritoneal Neoplasms | 2014 |
Synergistic effect of combinatorial treatment with curcumin and mitomycin C on the induction of apoptosis of breast cancer cells: a cDNA microarray analysis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Curcumin; Drug Synergism; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; MCF-7 Cells; Mice; Mice, Nude; Mitomycin; Oligonucleotide Array Sequence Analysis; Signal Transduction; Transplantation, Heterologous | 2014 |
Curcumin Improves the Tumoricidal Effect of Mitomycin C by Suppressing ABCG2 Expression in Stem Cell-Like Breast Cancer Cells.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Proliferation; Curcumin; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Indoles; MCF-7 Cells; Mitomycin; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplastic Stem Cells | 2015 |
ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Curcumin; Doxorubicin; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; NF-kappa B; Receptors, Androgen; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2019 |